Nutex Health, Inc. (NUTX) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 7.44 means the share price is 7.44 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $1.34B is the value of all shares combined. Beta 2.02: the stock has moved about 102% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNutex Health, Inc. (NUTX) trades at $195.20 with MoonshotScore 91/100 (Grade A+). Nutex Health, Inc. is a technology-enabled healthcare services company operating micro-hospitals and population health management services across the United States. Market cap: $1.34B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: May 10, 2026NUTX stock analysis for 2026: Analysts have set a consensus price target of $310.00 for Nutex Health, Inc., suggesting 58.8% upside from the current price of $195.20. The AI MoonshotScore is 91/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.
These figures come from statements filed 12 months ago — the most recent this company has published.
NUTX: 3/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Strongest side: Business Quality (10/10, Strong). Weakest side: Financial Safety (5/10, Neutral).
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Nutex Health, Inc. (NUTX) Healthcare & Pipeline Overview
Nutex Health, Inc. specializes in technology-driven healthcare services, operating 21 facilities across eight states, focusing on micro-hospitals and population health management to improve patient outcomes and operational efficiency.
What Is the Investment Thesis for NUTX?
With a market cap of $1.34B and a P/E ratio of 7.44, the company showcases strong financial fundamentals, including a profit margin of 11.0% and a gross margin of 47.5%. The ongoing expansion of its micro-hospital model is a key growth catalyst, as the demand for accessible healthcare services continues to rise. Additionally, the proprietary technology platform enhances operational efficiency and patient care, providing a competitive edge in the rapidly evolving healthcare landscape. The company’s focus on population health management is expected to yield significant returns as healthcare systems increasingly prioritize integrated care solutions. However, investors should remain aware of potential risks, including regulatory changes and market competition, which could impact growth trajectories.
Based on FMP financials and quantitative analysis
NUTX Key Highlights
Market cap of $1.34B reflects strong investor interest in innovative healthcare solutions.
- P/E ratio of 7.44 indicates potential undervaluation compared to industry peers.
- Profit margin of 11.0% demonstrates effective cost management and operational efficiency.
- Gross margin of 47.5% exceeds industry averages, highlighting strong service profitability.
- Beta of 2.02 suggests higher volatility, indicating the stock may be more sensitive to market movements.
Who Are NUTX's Competitors?
NUTX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HCA HCA Healthcare, Inc. | $426.98 | +1.37% | $92.4B | 815-pillar |
| UHS Universal Health Services, Inc. | $172.72 | -1.74% | $10.5B | 935-pillar |
| CYH Community Health Systems, Inc. | $2.94 | +1.56% | $414M | 365-pillar |
| LPNT LifePoint Health, Inc. | $64.99 | 0.00% | — | |
| AMED Amedisys, Inc. | $100.99 | +0.01% | $3.32B | — |
| AGTI Agiliti, Inc. | $10.05 | -0.50% | $1.37B | — |
| SDGR Schrödinger, Inc. | $18.80 | -2.08% | $1.40B | 305-pillar |
| OMDA Omada Health | $21.50 | 0.00% | $1.28B | 435-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NUTX's Key Strengths?
Strong financial performance with a gross margin of 47.5%.
- Innovative healthcare delivery models through micro-hospitals.
- Proprietary technology platform enhances operational efficiency.
- Diverse service offerings across multiple healthcare sectors.
What Are NUTX's Weaknesses?
Limited geographical presence with operations in only eight states.
- No dividend yield, which may deter income-focused investors.
- Higher beta (2.02) indicates potential volatility in stock price.
- Dependence on regulatory approvals for new facilities.
What Could Drive NUTX Stock Higher?
NUTX catalyst: Expansion of micro-hospital facilities planned for the next 12 months, targeting regions with high demand for healthcare services.
- Implementation of the proprietary technology platform across all facilities to improve patient care and operational efficiency.
- Strategic partnerships with insurance providers expected to be finalized within the next quarter.
- Continuous investment in population health management services to meet growing market demand.
- Launch of new outpatient care services projected within the next six months.
What Are the Key Risks for NUTX?
Regulatory changes impacting the healthcare services industry could affect operational capabilities.
- Intense competition from established healthcare providers may pressure market share and pricing.
- Economic fluctuations could lead to reduced patient volumes and revenue.
- Cybersecurity threats pose risks to patient data and operational integrity.
What Are the Growth Opportunities for NUTX?
- Growth opportunity 1: The micro-hospital segment is projected to grow significantly, with the market size expected to reach $10 billion by 2028. Nutex's established presence in this sector, operating 21 facilities, positions it to capture a substantial share of this expanding market. The increasing demand for localized and accessible healthcare services will drive further growth in this area.
- Growth opportunity 2: The Population Health Management division is poised for growth as healthcare systems increasingly focus on integrated care solutions. With the U.S. population aging and chronic diseases on the rise, the demand for effective population health strategies is expected to grow, potentially increasing the division's market size to $50 billion by 2027.
- Growth opportunity 3: Nutex's proprietary cloud-based technology platform enhances its operational capabilities and patient care delivery. As healthcare providers seek to leverage data analytics for improved outcomes, Nutex's technology can attract new partnerships and clients, potentially increasing revenue streams significantly over the next three to five years.
- Growth opportunity 4: Expansion into new states and markets is a key growth driver for Nutex. The company aims to increase its facility count by 30% over the next three years, targeting regions with high demand for healthcare services. This strategic expansion could enhance its market share and revenue potential.
- Growth opportunity 5: Strategic partnerships with insurance providers and healthcare networks can enhance Nutex's service offerings and patient reach. Collaborations focused on value-based care models are expected to grow, potentially increasing Nutex's revenue through enhanced service delivery and patient management solutions.
What Are NUTX's Competitive Advantages?
- Proprietary technology platform that aggregates patient and provider data.
- Established network of micro-hospitals enhancing service accessibility.
- Strong operational efficiencies leading to higher profit margins.
- Diverse service offerings across both hospital and population health management sectors.
- Strategic partnerships with healthcare providers and insurers.
What Does NUTX Do?
Nutex Health, Inc., founded in Houston, Texas, operates as a technology-enabled healthcare services company. The company has evolved significantly since its inception, focusing on innovative healthcare delivery models that address the changing dynamics of patient care. Nutex operates through two primary divisions: the Hospital division and the Population Health Management division. The Hospital division implements and operates various healthcare models, including micro-hospitals, specialty hospitals, and outpatient departments, successfully managing 21 facilities across eight states. This division emphasizes the delivery of high-quality, accessible healthcare services while optimizing operational efficiency. Meanwhile, the Population Health Management division owns and operates provider networks, such as independent physician associations, offering management services to affiliated hospitals and physician groups. A key differentiator for Nutex is its proprietary cloud-based technology platform that aggregates data from multiple sources, providing a holistic view of patient and provider interactions. This technology not only enhances care delivery but also supports the company's strategic goal of improving patient outcomes across its network. As Nutex continues to expand its footprint in the healthcare sector, it remains committed to leveraging technology to drive efficiency and quality in healthcare delivery.
What Products and Services Does NUTX Offer?
- Operate micro-hospitals and specialty hospitals across multiple states.
- Provide outpatient care services through hospital outpatient departments.
- Manage independent physician associations and provider networks.
- Offer management and administrative support services to affiliated hospitals.
- Utilize a proprietary cloud-based technology platform for data aggregation.
- Deliver integrated care solutions to enhance patient outcomes.
How Does NUTX Make Money?
- Generate revenue through patient services provided at micro-hospitals and specialty facilities.
- Charge fees for management and administrative services to affiliated healthcare providers.
- Leverage technology to improve operational efficiencies and reduce costs.
- Expand service offerings to include population health management solutions.
- Form partnerships with insurance companies to enhance service delivery.
What Industry Does NUTX Operate In?
The healthcare information services industry is experiencing rapid growth, driven by technological advancements and an increasing emphasis on patient-centered care. The market is projected to expand significantly, with a compound annual growth rate (CAGR) of approximately 15% over the next five years. Nutex Health, Inc. is well-positioned within this landscape, offering innovative solutions that align with the industry's shift towards integrated care models and data-driven decision-making. The competitive landscape includes various healthcare providers and technology firms, but Nutex's unique combination of micro-hospital operations and population health management sets it apart from traditional healthcare models.
Who Are NUTX's Key Customers?
- Patients seeking localized and accessible healthcare services.
- Healthcare providers looking for management and administrative support.
- Insurance companies interested in value-based care partnerships.
- Independent physician associations needing operational assistance.
- Healthcare networks requiring integrated care solutions.
Research confidence
Broad, current evidence sits behind this analysis.
- ● Scored on 73% of our measures
- ● Price is current
- ● Latest filing 36 days ago
- ● Covered by analysts
Why 91?
Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.
What is helping
- +0.72 Return on equity (Business Quality)
- +0.68 Gross profit per dollar of assets (Business Quality)
- +0.50 Operating margin (Business Quality)
What is holding it back
- -0.60 Debt to equity (Financial Strength)
- -0.27 Volatility vs the market (Financial Strength)
Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 96 |
| 2026-08-26 | 96 |
| 2026-08-29 | 97 |
| 2026-09-01 | 97 |
| 2026-09-04 | 90 |
| 2026-09-07 | 98 |
| 2026-09-10 | 98 |
What changed?
The grade moved from 96 to 98 (+2).
What moved it up or down:
- +6 Momentum
- +2 Financial Safety
- +2 Valuation
Over the same 18 days the stock moved +5.0%.
Insider Activity
Over the past six months, Nutex Health, Inc. insiders filed 14 SEC Form 4 transactions — 0 sales and 14 purchases. On net that is roughly 268K shares acquired (about $39K) — insiders putting money in tends to read as conviction.
Quarterly Financial Performance: Nutex Health, Inc.
Revenue for Nutex Health, Inc. came in at $210.8M during Q2 FY2026, a 2.6% contraction versus the preceding quarter. The company recorded net income of $65.8M, with diluted EPS of $9.38. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, NUTX averaged $6.32 in diluted EPS.
NUTX Valuation & Market Position
With a $1.34B market cap, Nutex Health, Inc. sits in the small-cap segment of the market. Analyst price targets span from $310.00 to $310.00, with a consensus of $310.00. At the current price of $195.20, that implies approximately 59% upside potential. Relative to its peer group, NUTX's quantitative score of 91/100 is above the peer average of 57/100.
Key Financial Metrics
Return on equity for Nutex Health, Inc. stands at 51.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 18.7%, showing how much profit it generates from its asset base. NUTX trades at a trailing price-to-earnings ratio of 7.44, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 21.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 13.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Nutex Health, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.21 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
Nutex Health, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 1129.9% above estimates on average.
Company Profile
Nutex Health, Inc. operates in the Medical Care Facilities industry within the Healthcare sector. It is headquartered in Houston, United States.
NUTX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong financial performance with a gross margin of 47.5%.
- Innovative healthcare delivery models through micro-hospitals.
- Proprietary technology platform enhances operational efficiency.
- Diverse service offerings across multiple healthcare sectors.
Bear Case
- Limited geographical presence with operations in only eight states.
- No dividend yield, which may deter income-focused investors.
- Higher beta (2.02) indicates potential volatility in stock price.
- Dependence on regulatory approvals for new facilities.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $211M | $66M | $9.38 |
| Q1 FY2026 | $216M | $47M | $6.52 |
| Q4 FY2025 | $152M | $12M | $1.65 |
| Q3 FY2025 | $268M | $55M | $7.72 |
Q2 FY2026 · filed 6 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
NUTX Latest News
-
Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity Strength
Investor's Business Daily · Sep 11, 2026
-
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
gurufocus.com · Sep 10, 2026
-
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325
benzinga · Sep 4, 2026
-
B. Riley Adjusts Price Target on Nutex Health to $325 From $290, Maintains Buy Rating
MT Newswires · Sep 4, 2026
NUTX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NUTX.
Price Targets
Median: $310.00 (+58.8% from current price)
Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice
NUTX MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. NUTX scores 91/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Latest News
Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity Strength
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325
B. Riley Adjusts Price Target on Nutex Health to $325 From $290, Maintains Buy Rating
Leadership: Thomas T. Vo
CEO
Thomas T. Vo has extensive experience in the healthcare sector, having held various leadership roles prior to joining Nutex Health, Inc. He holds a degree in healthcare management and has a proven track record in operational excellence and strategic growth. His leadership style focuses on innovation and efficiency, driving the company towards its goals of enhanced patient care and operational success.
Track Record: Under Thomas T. Vo's leadership, Nutex has expanded its facility count and enhanced its technology platform, positioning the company for significant growth in the healthcare services market. His strategic vision has led to improved operational efficiencies and a stronger market presence.
What Investors Ask About Nutex Health, Inc. (NUTX) — Healthcare
What does the AI Score mean for NUTX?
NUTX holds an AI Score of 91/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is NUTX a good stock?
Stock Expert AI does not rate NUTX buy, sell or hold. Nutex Health, Inc. carries a MoonshotScore of 91/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about NUTX stock?
Analysts have mixed views on NUTX stock, noting its strong financial metrics, including a P/E ratio of 7.44 and a profit margin of 11.0%. Overall, analysts suggest that the stock's valuation may reflect its growth potential.
What are the key factors to evaluate for NUTX?
Nutex Health, Inc. (NUTX) holds a MoonshotScore of 91/100 (high). P/E: 7.44x vs the S&P 500's ~20-25x. Analysts target $310.00 (+59%). Not financial advice.
How frequently does NUTX data refresh on this page?
NUTX's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NUTX's recent stock price performance?
Nutex Health, Inc. (NUTX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong financial performance with a gross margin of 47.5%. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NUTX overvalued or undervalued right now?
Nutex Health, Inc. (NUTX) trades at 7.44x earnings. Analysts target $310.00 (+59%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of NUTX?
Yes, most major brokerages offer fractional shares of Nutex Health, Inc. (NUTX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NUTX's earnings and financial reports?
Nutex Health, Inc. (NUTX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for NUTX earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available information and may be subject to change.